NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,043,666 | -16.9% | 136,580 | -8.6% | 0.00% | 0.0% |
| Q2 2023 | $7,269,123 | -1.5% | 149,386 | +12.4% | 0.00% | -33.3% |
| Q1 2023 | $7,380,553 | +32.4% | 132,935 | -4.2% | 0.00% | +50.0% |
| Q4 2022 | $5,574,390 | +1.3% | 138,770 | +10.5% | 0.00% | 0.0% |
| Q3 2022 | $5,503,000 | +8.0% | 125,590 | -12.6% | 0.00% | 0.0% |
| Q2 2022 | $5,094,000 | +2.7% | 143,747 | +17.9% | 0.00% | 0.0% |
| Q1 2022 | $4,959,000 | -52.1% | 121,890 | +9.9% | 0.00% | -33.3% |
| Q4 2021 | $10,362,000 | -3.8% | 110,946 | +14.7% | 0.00% | -25.0% |
| Q3 2021 | $10,776,000 | +12.1% | 96,697 | +14.2% | 0.00% | +33.3% |
| Q2 2021 | $9,610,000 | +50.3% | 84,640 | +34.5% | 0.00% | +50.0% |
| Q1 2021 | $6,392,000 | +1.3% | 62,940 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $6,307,000 | +65.5% | 63,375 | +20.1% | 0.00% | 0.0% |
| Q3 2020 | $3,812,000 | +35.0% | 52,770 | -6.8% | 0.00% | +100.0% |
| Q2 2020 | $2,824,000 | +109.2% | 56,635 | +26.8% | 0.00% | 0.0% |
| Q1 2020 | $1,350,000 | +16.7% | 44,680 | +30.1% | 0.00% | 0.0% |
| Q4 2019 | $1,157,000 | +14.4% | 34,332 | +11.4% | 0.00% | 0.0% |
| Q3 2019 | $1,011,000 | +201.8% | 30,823 | +154.2% | 0.00% | – |
| Q2 2019 | $335,000 | +163.8% | 12,125 | +96.1% | 0.00% | – |
| Q1 2019 | $127,000 | +56.8% | 6,183 | +6.1% | 0.00% | – |
| Q4 2018 | $81,000 | -33.6% | 5,826 | +14.5% | 0.00% | – |
| Q3 2018 | $122,000 | +20.8% | 5,090 | -4.7% | 0.00% | – |
| Q2 2018 | $101,000 | +83.6% | 5,340 | -10.3% | 0.00% | – |
| Q1 2018 | $55,000 | -25.7% | 5,950 | -27.7% | 0.00% | – |
| Q4 2017 | $74,000 | -32.1% | 8,235 | -2.7% | 0.00% | – |
| Q3 2017 | $109,000 | +19.8% | 8,460 | 0.0% | 0.00% | – |
| Q2 2017 | $91,000 | +37.9% | 8,460 | +14.2% | 0.00% | – |
| Q1 2017 | $66,000 | -24.1% | 7,411 | -0.7% | 0.00% | – |
| Q4 2016 | $87,000 | +117.5% | 7,464 | +96.9% | 0.00% | – |
| Q3 2016 | $40,000 | -59.6% | 3,790 | -54.2% | 0.00% | – |
| Q2 2016 | $99,000 | – | 8,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |